Opioid Analgesic Prescription in French Children: A National Population-Based Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
17 12 2021
Historique:
received: 10 11 2021
revised: 14 12 2021
accepted: 15 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 31 12 2021
Statut: epublish

Résumé

Codeine use was restricted in 2013 and is currently contraindicated for children below the age of 12 years. We examined how the prescription of opioid analgesics in children in France evolved between 2012 and 2018. Our population-based study from the SNIIRAM database (National System of Health Insurance Inter-Regime Information) was designed to determine trends in opioid prescription from 2012 to 2018 in all French children. The number of children who received at least one opioid prescription gradually declined from 452,665 in 2012 (347.5 children per 10,000) to 169,338 in 2018 (130.3 children per 10,000). This decrease was especially marked for codeine (36 children per 10,000 in 2018 vs. 308.5 children per 10,000 in 2012), whereas the number of tramadol prescriptions increased by 171% in 2018 (94.6 children per 10,000). Despite the increase, strong opioids still formed only a small proportion of prescriptions (2.6 children per 10,000 given opioids in 2018). Overall opioid prescriptions in French children dramatically decreased between 2012 and 2018, probably owing to restrictions on the use of codeine. Codeine has been partly replaced by tramadol. Morphine is still probably underused. This suggests that opioids are being used less often for pain management in children.

Identifiants

pubmed: 34948923
pii: ijerph182413316
doi: 10.3390/ijerph182413316
pmc: PMC8702064
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Tramadol 39J1LGJ30J
Morphine 76I7G6D29C
Codeine UX6OWY2V7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):231-4
pubmed: 14726731
Res Nurs Health. 2009 Oct;32(5):530-9
pubmed: 19504564
Arch Pediatr. 2019 Feb;26(2):80-85
pubmed: 30638927
Pediatr Emerg Care. 2007 Sep;23(9):627-33
pubmed: 17876251
Eur J Pain. 2015 Sep;19(8):1095-100
pubmed: 25410553
Eur J Pain. 2019 Jan;23(1):124-134
pubmed: 30051548
Pain Med. 2014 May;15(5):807-19
pubmed: 24401078
Can Pharm J (Ott). 2012 Nov;145(6):276-279.e1
pubmed: 23509589
JAMA Netw Open. 2018 Dec 7;1(8):e186161
pubmed: 30646317
Otolaryngol Head Neck Surg. 2013 Feb;148(2):356-7
pubmed: 23355375
Pediatrics. 2015 Mar;135(3):e753-5
pubmed: 25647677
JAMA Pediatr. 2021 Oct 1;175(10):1043-1052
pubmed: 34180978
Pediatrics. 2016 May;137(5):
pubmed: 27244829
Br J Clin Pharmacol. 2018 Jun;84(6):1324-1334
pubmed: 29514410
J Pain Palliat Care Pharmacother. 2015;29(4):353-8
pubmed: 26654407
Lancet Reg Health Eur. 2021 Jun 07;7:100129
pubmed: 34557839
Pain. 2016 May;157(5):1021-1027
pubmed: 26716995
Arch Dis Child. 2020 Dec;105(12):1229-1232
pubmed: 32819915
Anesth Analg. 2016 Mar;122(3):807-813
pubmed: 26579844
JAMA Surg. 2021 Jan 1;156(1):76-90
pubmed: 33175130
Eur J Public Health. 2008 Jun;18(3):312-6
pubmed: 18160392
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962
pubmed: 28544284
Ann Emerg Med. 2009 Oct;54(4):553-60
pubmed: 19692147
Br J Pharmacol. 2010 Jun;160(4):907-18
pubmed: 20590587
Ann Emerg Med. 2003 May;41(5):617-22
pubmed: 12712027
PLoS One. 2021 Sep 9;16(9):e0257021
pubmed: 34499688
Lancet Child Adolesc Health. 2019 Dec;3(12):881-888
pubmed: 31604614
Pediatrics. 2015 Nov;136(5):e1169-77
pubmed: 26504126
Pharmacogenomics. 2017 Mar;18(4):337-348
pubmed: 28244808
Paediatr Anaesth. 2012 Jul;22(7):661-8
pubmed: 22332912
Front Pharmacol. 2018 Mar 05;9:148
pubmed: 29556194
J Pediatr Surg. 2019 Oct;54(10):1984-1987
pubmed: 30879744
Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1086-1096
pubmed: 31219227

Auteurs

Samira Choufi (S)

Pédiatrie, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.

Simon Mounier (S)

Pédiatrie, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.

Etienne Merlin (E)

Pédiatrie, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
CIC 1405, Unité CRECHE, INSERM, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Emmanuelle Rochette (E)

Pédiatrie, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
CIC 1405, Unité CRECHE, INSERM, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Jessica Delorme (J)

CHU Clermont-Ferrand, Inserm 1107, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Université Clermont Auvergne, F-63003 Clermont-Ferrand, France.
Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.

Nicolas Authier (N)

CHU Clermont-Ferrand, Inserm 1107, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Université Clermont Auvergne, F-63003 Clermont-Ferrand, France.
Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.
Institut Analgesia, Faculté de Médecine, F-63001 Clermont-Ferrand, France.

Chouki Chenaf (C)

CHU Clermont-Ferrand, Inserm 1107, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Université Clermont Auvergne, F-63003 Clermont-Ferrand, France.
Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.
Institut Analgesia, Faculté de Médecine, F-63001 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH